Panel discussion.

Open Access

Panel discussion.

Session: Unleashing the potential benefits of guideline-directed heart failure treatments

Topic: Chronic Heart Failure

Speaker: Doctor A. Bayes Genis (Badalona, ES) Professor M. Petrie (Glasgow, GB) Associate Professor M. Cikes (Zagreb, HR) Professor W. Mullens (Genk, BE)

About the speakers

Doctor Antonio Bayes Genis

University Hospital Germans Trias and Pujol de Badalona, Badalona (Spain)

52 presentations

12 followers

Professor Mark Petrie

University of Glasgow, Glasgow (United Kingdom of Great Britain & Northern Ireland)

40 presentations

8 followers

Associate Professor Maja Cikes

University Hospital Centre Zagreb, Zagreb (Croatia)

41 presentations

12 followers

Professor Wilfried Mullens

Hospital Oost-Limburg (ZOL), Genk (Belgium)

80 presentations

63 followers

7 more presentations in this session

Welcome and introduction.

Speaker: Doctor A. Bayes Genis (Badalona, ES)

Access

Slides

Video

Can we change the outlook for patients with HFrEF?

Speaker: Professor M. Petrie (Glasgow, GB)

Access

Video

Panel discussion.

Speaker: Doctor A. Bayes Genis (Badalona, ES) Professor M. Petrie (Glasgow, GB) Associate Professor M. Cikes (Zagreb, HR) Professor W. Mullens (Genk, BE)

Access

Video

Optimising treatment for hospitalised HF patients: what, when and how?

Speaker: Associate Professor M. Cikes (Zagreb, HR)

Access

Video

Heart failure and comorbidities - what should we consider?

Speaker: Professor W. Mullens (Genk, BE)

Access

Video

Access the full session

Unleashing the potential benefits of guideline-directed heart failure treatments

Speakers: Doctor A. Bayes Genis, Professor M. Petrie, Associate Professor M. Cikes, Professor W. Mullens, Doctor A. Bayes Genis...

Access

Video

About the event

Heart Failure 2022

21 May - 24 May 2022

Sessions Presentations

Congress

Panel discussion.

About the speakers

Doctor Antonio Bayes Genis

Professor Mark Petrie

Associate Professor Maja Cikes

Professor Wilfried Mullens

7 more presentations in this session

Welcome and introduction.

Can we change the outlook for patients with HFrEF?

Panel discussion.

Optimising treatment for hospitalised HF patients: what, when and how?

Heart failure and comorbidities - what should we consider?

Access the full session

Unleashing the potential benefits of guideline-directed heart failure treatments

About the event

Heart Failure 2022

ESC 365 is supported by